药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Estazolam
Ciclesonide
The risk or severity of adverse effects can be increased when Ciclesonide is combined with Pralatrexate.
Estazolam
Paramethasone
The risk or severity of adverse effects can be increased when Paramethasone is combined with Pralatrexate.
Estazolam
Cortisone acetate
The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Pralatrexate.
Estazolam
Corticotropin
The risk or severity of adverse effects can be increased when Corticotropin is combined with Pralatrexate.
Estazolam
Abatacept
The risk or severity of adverse effects can be increased when Abatacept is combined with Pralatrexate.
Estazolam
Nelarabine
The risk or severity of adverse effects can be increased when Nelarabine is combined with Pralatrexate.
Estazolam
Eculizumab
The risk or severity of adverse effects can be increased when Eculizumab is combined with Pralatrexate.
Estazolam
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Pralatrexate.
Metipranolol
Potassium cation
Potassium cation may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.
Metipranolol
Potassium
Potassium may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.
Metipranolol
Bromotheophylline
Bromotheophylline may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.
Metipranolol
Epitizide
Epitizide may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.
Metipranolol
Xipamide
Xipamide may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.
Metipranolol
Muzolimine
Muzolimine may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.
Metipranolol
Clopamide
Clopamide may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.
Metipranolol
Fenquizone
Fenquizone may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.
Metipranolol
Clofenamide
Clofenamide may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.
Metipranolol
Clorexolone
Clorexolone may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.
Metipranolol
Cyclopenthiazide
Cyclopenthiazide may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.
Metipranolol
Mebutizide
Mebutizide may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.